menu close
www.clicktherapeutics.com

Click Therapeutics Stock

Company Profile:

Click Therapeutics is a biotechnology company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs.

Sign up for SecondMarket™ to view the market and buy or sell Click Therapeutics Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Click Therapeutics Management Team

  • Chief Technology Officer

    Han Chiu

  • Chief People Officer

    Usha Dantu

  • Chief Medical Officer

    Shaheen Lakhan

  • Chief Financial Officer

    Randall Stanicky

  • Chief Legal Officer

    Tarique Collins

  • Chief Commercial Officer

    Richard DeNunzio

  • Chief Strategy Officer

    Austin C. Speier

  • Chief Executive Officer

    David B. Klein

Click Therapeutics Major Investors

  • H.I.G. BioHealth Partners

  • Sanofi Ventures

  • Health Catalyst Capital

  • Revelation Partners

  • Ridgetop Health

  • Flatiron Investors

  • Hikma Ventures

  • Magellan Health Services

  • HSBC Innovation Banking

  • Otsuka Holdings

  • Accelmed

  • K2 HealthVentures

Learn More About Click Therapeutics Stock

Buy Click Therapeutics Stock
01

Click Therapeutics stock does not trade on public stock exchanges. Click Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Click Therapeutics stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Click Therapeutics Stock
02

Click Therapeutics Stock does not trade on public stock exchanges. In order to sell Click Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Click Therapeutics Stock Price
03

Click Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Click Therapeutics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Click Therapeutics Stock Ticker Symbol
04

There is no ticker symbol for Click Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Click Therapeutics Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Click Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Click Therapeutics Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Click Therapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Click Therapeutics Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Click Therapeutics IPO
08

Click Therapeutics is a private company and has not had an IPO. There is currently no Click Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Click Therapeutics IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell Click Therapeutics Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Health

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Neuron23 Inc-Logo

Neuron23

Biotechnology company focused on developing personalized medicines for genetic disorders.

Geltor

Animal-free, category-defining ingredients.

Dren Bio

Developing powerful protein engineering technologies to deplete cells, protein aggregates and other disease-causing agents.

Source: Nasdaq Private Market Tape D™